Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Prostate Cancer
In brief
RATIONALE: Celecoxib may be an effective treatment for early stage prostate cancer. It is not yet known if celecoxib is more effective than no treatment before surgery for prostate cancer. PURPOSE: Randomized phase I trial to determine the effectiveness of celecoxib given before surgery to remove the prostate in treating patients who have localized prostate cancer.
Key facts
- Study ID
- NCT00022399
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- People needed
- 73
- Starts
- 2002-04-25
- Expected to finish
- 2005-01-31
- Last updated by the study team
- 2019-02-08
Who can join
Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.